Literature DB >> 24760686

MicroRNA-1 (miR-1) inhibits chordoma cell migration and invasion by targeting slug.

Eiji Osaka1, Xiaoqian Yang, Jacson K Shen, Pei Yang, Yong Feng, Henry J Mankin, Francis J Hornicek, Zhenfeng Duan.   

Abstract

Recent studies have revealed that expression of miRNA-1 (miR-1) is frequently down-regulated in several cancer types including chordoma. Identifying and validating novel targets of miR-1 is useful for understanding the roles of miR-1 in chordoma. We aimed to further investigate the functions of miR-1 in chordoma. Specifically, we assessed whether restoration of miR-1 affects cell migration and invasion in chordoma, and focused on the miR-1 potential target Slug gene. Migratory and invasive activities were assessed by wound healing and Matrigel invasion assays, respectively. Cell proliferation was determined by MTT assay. Slug expression was evaluated by Western blot, immunofluorescence, and immunohistochemistry. Restoration of miR-1 expression suppressed the migratory and invasive activities of chordoma cells. Transfection of miR-1 inhibited cell proliferation both time- and dose-dependently in chordoma. MiR-1 transfected cells showed inhibited Slug expression. Slug was over-expressed in chordoma cell lines and advanced chordoma tissues. In conclusion, we have shown that miR-1 directly targets the Slug gene in chordoma. Restoration of miR-1 suppressed not only proliferation, but also migratory and invasive activities, and reduced the Slug expression in chordoma cells. These results collectively indicate that miR-1/Slug pathway is a potential therapeutic target because of its crucial roles in chordoma cell growth and migration.
© 2014 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  chordoma; invasion; miRNA-1 (miR-1); migration; slug

Mesh:

Substances:

Year:  2014        PMID: 24760686      PMCID: PMC4123853          DOI: 10.1002/jor.22632

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  31 in total

1.  Increased Slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancer.

Authors:  Yasuto Uchikado; Hiroshi Okumura; Sumiya Ishigami; Tetsuro Setoyama; Masataka Matsumoto; Tetsuhiro Owaki; Yoshiaki Kita; Shoji Natsugoe
Journal:  Gastric Cancer       Date:  2011-01-28       Impact factor: 7.370

2.  Clinical significance of a wide excision policy for sacrococcygeal chordoma.

Authors:  Shunzo Osaka; Osamu Kodoh; Hideyuki Sugita; Eiji Osaka; Yoshiyuki Yoshida; Junnosuke Ryu
Journal:  J Cancer Res Clin Oncol       Date:  2005-12-16       Impact factor: 4.553

3.  Operative management of sacral chordoma.

Authors:  Bruno Fuchs; Ian D Dickey; Michael J Yaszemski; Carrie Y Inwards; Franklin H Sim
Journal:  J Bone Joint Surg Am       Date:  2005-10       Impact factor: 5.284

Review 4.  The EMT regulator slug and lung carcinogenesis.

Authors:  Jin-Yuan Shih; Pan-Chyr Yang
Journal:  Carcinogenesis       Date:  2011-06-10       Impact factor: 4.944

5.  The functional significance of miR-1 and miR-133a in renal cell carcinoma.

Authors:  Kazumori Kawakami; Hideki Enokida; Takeshi Chiyomaru; Shuichi Tatarano; Hirofumi Yoshino; Ichiro Kagara; Takenari Gotanda; Tokushi Tachiwada; Kenryu Nishiyama; Nijiro Nohata; Naohiko Seki; Masayuki Nakagawa
Journal:  Eur J Cancer       Date:  2012-04       Impact factor: 9.162

6.  Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1.

Authors:  S Scheil; S Brüderlein; T Liehr; H Starke; J Herms; M Schulte; P Möller
Journal:  Genes Chromosomes Cancer       Date:  2001-11       Impact factor: 5.006

7.  Expression of transcription factors snail, slug, and twist in human bladder carcinoma.

Authors:  Qinchao Yu; Kejun Zhang; Xinsheng Wang; Xiangping Liu; Zemi Zhang
Journal:  J Exp Clin Cancer Res       Date:  2010-09-01

8.  MicroRNA-1 inhibits proliferation of hepatocarcinoma cells by targeting endothelin-1.

Authors:  Dong Li; Pengyuan Yang; Hua Li; Peng Cheng; Ling Zhang; Dong Wei; Xiaomei Su; Jingjing Peng; Hui Gao; Yong Tan; Zhenguo Zhao; Yan Li; Zhongchun Qi; Yaocheng Rui; Tao Zhang
Journal:  Life Sci       Date:  2012-08-20       Impact factor: 5.037

Review 9.  miRNAs in human cancer.

Authors:  Thalia A Farazi; Jessica I Spitzer; Pavel Morozov; Thomas Tuschl
Journal:  J Pathol       Date:  2010-11-18       Impact factor: 7.996

10.  Stability and prognostic value of Slug, Sox9 and Sox10 expression in breast cancers treated with neoadjuvant chemotherapy.

Authors:  Cosima Riemenschnitter; Ivett Teleki; Verena Tischler; Wenjun Guo; Zsuzsanna Varga
Journal:  Springerplus       Date:  2013-12-28
View more
  21 in total

1.  Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system.

Authors:  Yong Feng; Slim Sassi; Jacson K Shen; Xiaoqian Yang; Yan Gao; Eiji Osaka; Jianming Zhang; Shuhua Yang; Cao Yang; Henry J Mankin; Francis J Hornicek; Zhenfeng Duan
Journal:  J Orthop Res       Date:  2014-10-27       Impact factor: 3.494

Review 2.  MicroRNAs in the pathobiology of sarcomas.

Authors:  Anne E Sarver; Subbaya Subramanian
Journal:  Lab Invest       Date:  2015-06-29       Impact factor: 5.662

Review 3.  The roles of microRNAs related with progression and metastasis in human cancers.

Authors:  Hai-Ting Liu; Peng Gao
Journal:  Tumour Biol       Date:  2016-10-06

4.  Recurrence and survival factors analysis of 171 cases of sacral chordoma in a single institute.

Authors:  Yongkun Yang; Xiaohui Niu; Yuan Li; Weifeng Liu; Hairong Xu
Journal:  Eur Spine J       Date:  2016-12-09       Impact factor: 3.134

Review 5.  Epigenetic deregulations in chordoma.

Authors:  Xin Yu; Zheng Li
Journal:  Cell Prolif       Date:  2015-08-10       Impact factor: 6.831

Review 6.  Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease.

Authors:  Keith Richard Mitchelson; Wen-Yan Qin
Journal:  World J Biol Chem       Date:  2015-08-26

7.  miR-497 inhibits epithelial mesenchymal transition in breast carcinoma by targeting Slug.

Authors:  Zhihao Wu; Xiangli Li; Xuehong Cai; Chenggang Huang; Min Zheng
Journal:  Tumour Biol       Date:  2015-12-23

8.  Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma.

Authors:  Yong Feng; Jacson Shen; Yan Gao; Yunfei Liao; Gregory Cote; Edwin Choy; Ivan Chebib; Henry Mankin; Francis Hornicek; Zhenfeng Duan
Journal:  Oncotarget       Date:  2015-05-10

9.  MicroRNA-1 (miR-1) inhibits gastric cancer cell proliferation and migration by targeting MET.

Authors:  Chao Han; Yubing Zhou; Qi An; Feng Li; Duolu Li; Xiaojian Zhang; Zujing Yu; Lili Zheng; Zhenfeng Duan; Quancheng Kan
Journal:  Tumour Biol       Date:  2015-04-01

Review 10.  MicroRNA-1 in Cardiac Diseases and Cancers.

Authors:  Jianzhe Li; Xiaomin Dong; Zhongping Wang; Jianhua Wu
Journal:  Korean J Physiol Pharmacol       Date:  2014-10-17       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.